According to the same study, inhibition of the chemerin/CMKLR1 axis exhibited antitumor effects in vitro and in vivo, suggesting that the chemerin/CMKLR1 axis could be a potential therapeutic target for neuroblastoma. Here, CMKLR1 is linked to neuroblastoma.